DOCGO INC (DCGO) Fundamental Analysis & Valuation

NASDAQ:DCGO • US2560861096

0.6719 USD
-0.03 (-4.36%)
At close: Mar 6, 2026
0.674 USD
+0 (+0.31%)
After Hours: 3/6/2026, 8:11:07 PM

This DCGO fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

3

Overall DCGO gets a fundamental rating of 3 out of 10. We evaluated DCGO against 101 industry peers in the Health Care Providers & Services industry. DCGO has a great financial health rating, but its profitability evaluates not so good. DCGO has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

2

1. DCGO Profitability Analysis

1.1 Basic Checks

  • DCGO had negative earnings in the past year.
  • DCGO had a positive operating cash flow in the past year.
  • DCGO had positive earnings in 4 of the past 5 years.
  • The reported operating cash flow has been mixed in the past 5 years: DCGO reported negative operating cash flow in multiple years.
DCGO Yearly Net Income VS EBIT VS OCF VS FCFDCGO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 50M -50M

1.2 Ratios

  • The Return On Assets of DCGO (-14.58%) is worse than 78.22% of its industry peers.
  • DCGO has a worse Return On Equity (-19.07%) than 65.35% of its industry peers.
Industry RankSector Rank
ROA -14.58%
ROE -19.07%
ROIC N/A
ROA(3y)4.86%
ROA(5y)1.57%
ROE(3y)7.06%
ROE(5y)1.16%
ROIC(3y)N/A
ROIC(5y)N/A
DCGO Yearly ROA, ROE, ROICDCGO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 10 -10 -20

1.3 Margins

  • DCGO's Profit Margin has declined in the last couple of years.
  • In the last couple of years the Operating Margin of DCGO has declined.
  • DCGO's Gross Margin of 31.21% is fine compared to the rest of the industry. DCGO outperforms 60.40% of its industry peers.
  • In the last couple of years the Gross Margin of DCGO has remained more or less at the same level.
  • DCGO does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 31.21%
OM growth 3Y-8.41%
OM growth 5YN/A
PM growth 3Y-24.17%
PM growth 5YN/A
GM growth 3Y0.21%
GM growth 5YN/A
DCGO Yearly Profit, Operating, Gross MarginsDCGO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

7

2. DCGO Health Analysis

2.1 Basic Checks

  • DCGO does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for DCGO has been reduced compared to 1 year ago.
  • The debt/assets ratio for DCGO is higher compared to a year ago.
DCGO Yearly Shares OutstandingDCGO Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
DCGO Yearly Total Debt VS Total AssetsDCGO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

  • DCGO has an Altman-Z score of 1.14. This is a bad value and indicates that DCGO is not financially healthy and even has some risk of bankruptcy.
  • DCGO's Altman-Z score of 1.14 is on the low side compared to the rest of the industry. DCGO is outperformed by 64.36% of its industry peers.
  • DCGO has a debt to FCF ratio of 0.32. This is a very positive value and a sign of high solvency as it would only need 0.32 years to pay back of all of its debts.
  • DCGO's Debt to FCF ratio of 0.32 is amongst the best of the industry. DCGO outperforms 91.09% of its industry peers.
  • DCGO has a Debt/Equity ratio of 0.04. This is a healthy value indicating a solid balance between debt and equity.
  • DCGO has a better Debt to Equity ratio (0.04) than 81.19% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 0.32
Altman-Z 1.14
ROIC/WACCN/A
WACC7.97%
DCGO Yearly LT Debt VS Equity VS FCFDCGO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

  • A Current Ratio of 2.59 indicates that DCGO has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 2.59, DCGO belongs to the top of the industry, outperforming 83.17% of the companies in the same industry.
  • DCGO has a Quick Ratio of 2.59. This indicates that DCGO is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 2.59, DCGO belongs to the top of the industry, outperforming 83.17% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.59
Quick Ratio 2.59
DCGO Yearly Current Assets VS Current LiabilitesDCGO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 100M 200M 300M

2

3. DCGO Growth Analysis

3.1 Past

  • DCGO shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -194.14%.
  • The Earnings Per Share has been decreasing by -9.93% on average over the past years.
  • The Revenue for DCGO has decreased by -47.03% in the past year. This is quite bad
  • The Revenue has been growing by 24.60% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-194.14%
EPS 3Y-9.93%
EPS 5YN/A
EPS Q2Q%-326%
Revenue 1Y (TTM)-47.03%
Revenue growth 3Y24.6%
Revenue growth 5YN/A
Sales Q2Q%-48.94%

3.2 Future

  • The Earnings Per Share is expected to decrease by -42.21% on average over the next years. This is quite bad
  • DCGO is expected to show a very negative growth in Revenue. In the coming years, the Revenue will decrease by -20.13% yearly.
EPS Next Y-311.85%
EPS Next 2Y-83.02%
EPS Next 3Y-42.21%
EPS Next 5YN/A
Revenue Next Year-49.19%
Revenue Next 2Y-31.73%
Revenue Next 3Y-20.13%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
DCGO Yearly Revenue VS EstimatesDCGO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M
DCGO Yearly EPS VS EstimatesDCGO Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 -0.4

2

4. DCGO Valuation Analysis

4.1 Price/Earnings Ratio

  • DCGO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for DCGO. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DCGO Price Earnings VS Forward Price EarningsDCGO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

  • 100.00% of the companies in the same industry are more expensive than DCGO, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 1.27
EV/EBITDA N/A
DCGO Per share dataDCGO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

  • A cheap valuation may be justified as DCGO's earnings are expected to decrease with -42.21% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-83.02%
EPS Next 3Y-42.21%

0

5. DCGO Dividend Analysis

5.1 Amount

  • DCGO does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

DCGO Fundamentals: All Metrics, Ratios and Statistics

DOCGO INC

NASDAQ:DCGO (3/6/2026, 8:11:07 PM)

After market: 0.674 +0 (+0.31%)

0.6719

-0.03 (-4.36%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-10
Earnings (Next)03-16
Inst Owners50.6%
Inst Owner Change-15.11%
Ins Owners9.01%
Ins Owner Change14.71%
Market Cap65.72M
Revenue(TTM)368.09M
Net Income(TTM)-51.59M
Analysts78.33
Price Target2.55 (279.52%)
Short Float %6.68%
Short Ratio8.18
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-5.06%
Min EPS beat(2)-14.37%
Max EPS beat(2)4.26%
EPS beat(4)1
Avg EPS beat(4)-85.28%
Min EPS beat(4)-311.74%
Max EPS beat(4)4.26%
EPS beat(8)3
Avg EPS beat(8)-44.96%
EPS beat(12)4
Avg EPS beat(12)-60.37%
EPS beat(16)7
Avg EPS beat(16)32.87%
Revenue beat(2)1
Avg Revenue beat(2)0.57%
Min Revenue beat(2)-0.5%
Max Revenue beat(2)1.64%
Revenue beat(4)1
Avg Revenue beat(4)-4.25%
Min Revenue beat(4)-9.68%
Max Revenue beat(4)1.64%
Revenue beat(8)3
Avg Revenue beat(8)-2.27%
Revenue beat(12)6
Avg Revenue beat(12)0.87%
Revenue beat(16)10
Avg Revenue beat(16)15.35%
PT rev (1m)0%
PT rev (3m)-9.09%
EPS NQ rev (1m)1.25%
EPS NQ rev (3m)-18.16%
EPS NY rev (1m)0%
EPS NY rev (3m)-28.57%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.3%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.02%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.18
P/FCF 1.27
P/OCF 1.14
P/B 0.24
P/tB 0.31
EV/EBITDA N/A
EPS(TTM)-0.27
EYN/A
EPS(NY)-0.35
Fwd EYN/A
FCF(TTM)0.53
FCFY78.87%
OCF(TTM)0.59
OCFY87.96%
SpS3.76
BVpS2.77
TBVpS2.16
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -14.58%
ROE -19.07%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 31.21%
FCFM 14.08%
ROA(3y)4.86%
ROA(5y)1.57%
ROE(3y)7.06%
ROE(5y)1.16%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)8.11%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-8.41%
OM growth 5YN/A
PM growth 3Y-24.17%
PM growth 5YN/A
GM growth 3Y0.21%
GM growth 5YN/A
F-Score4
Asset Turnover1.04
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 0.32
Debt/EBITDA N/A
Cap/Depr 39.73%
Cap/Sales 1.62%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.59
Quick Ratio 2.59
Altman-Z 1.14
F-Score4
WACC7.97%
ROIC/WACCN/A
Cap/Depr(3y)50.15%
Cap/Depr(5y)71.98%
Cap/Sales(3y)1.27%
Cap/Sales(5y)2.53%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-194.14%
EPS 3Y-9.93%
EPS 5YN/A
EPS Q2Q%-326%
EPS Next Y-311.85%
EPS Next 2Y-83.02%
EPS Next 3Y-42.21%
EPS Next 5YN/A
Revenue 1Y (TTM)-47.03%
Revenue growth 3Y24.6%
Revenue growth 5YN/A
Sales Q2Q%-48.94%
Revenue Next Year-49.19%
Revenue Next 2Y-31.73%
Revenue Next 3Y-20.13%
Revenue Next 5YN/A
EBIT growth 1Y-223.09%
EBIT growth 3Y14.13%
EBIT growth 5YN/A
EBIT Next Year-161.07%
EBIT Next 3Y-27.6%
EBIT Next 5YN/A
FCF growth 1Y168.72%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y186.23%
OCF growth 3YN/A
OCF growth 5YN/A

DOCGO INC / DCGO FAQ

What is the fundamental rating for DCGO stock?

ChartMill assigns a fundamental rating of 3 / 10 to DCGO.


What is the valuation status of DOCGO INC (DCGO) stock?

ChartMill assigns a valuation rating of 2 / 10 to DOCGO INC (DCGO). This can be considered as Overvalued.


How profitable is DOCGO INC (DCGO) stock?

DOCGO INC (DCGO) has a profitability rating of 2 / 10.


What is the financial health of DOCGO INC (DCGO) stock?

The financial health rating of DOCGO INC (DCGO) is 7 / 10.